3Sbio Inc. (SSRS) 20-F Annual Report April 2013

SSRS Annual Reports

SSRS Corporate News

6-K Foreign Issuer Report

May 2011

3Sbio Inc.

HISTORY TOOLS

CIK: 1383790 Ticker: SSRS

Please wait while we load the requested 20-F report or click the link below:

https://last10k.com/sec-filings/report/1383790/000106299313002196/form20f.htm

View differences made from one year to another to evaluate 3Sbio Inc.'s financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 20-F Annual Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by 3Sbio Inc..

Continue

Assess how 3Sbio Inc.'s management team is paid from their Annual Proxy

3Sbio Inc.'s Definitive Proxy Statement (Form DEF 14A) filed after their 2013 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Material Contracts, Statements, Certifications & more

3Sbio Inc. provided additional information to their SEC Filing as exhibits

Exhibit 4.16: Amendment To Business Cooperation Agreement

Exhibit 4.17: Supplement No. 1 To Purchase Agreement For The Acquisition Of Equity Interest

Exhibit 4.18: Supplement No. 2 To Purchase Agreement For The Acquisition Of Equity Interest

Exhibit 4.19: Amendment To Purchase Agreement For The Acquisition Of Equity Interest

Exhibit 4.20: Amendment To Voting Rights Agreement

Exhibit 4.21: Amendment To Equity Pledge Agreement

Exhibit 8.1: List Of Subsidiaries Of 3Sbio Inc.

Exhibit 12.1: Ceo Certification - Section 302

Exhibit 12.2: Cfo Certification - Section 302

Exhibit 13.1: Ceo Certification - Section 906

Exhibit 13.2: Cfo Certification - Section 906

Exhibit 15.1: Consent Of Ernst &Amp; Young Hua Ming Llp

Ticker: SSRS
CIK: 1383790
Form Type: 20-F Annual Report
Accession Number: 0001062993-13-002196
Submitted to the SEC: Tue Apr 30 2013 5:08:51 PM EST
Accepted by the SEC: Tue Apr 30 2013
Period: Monday, December 31, 2012
Industry: Pharmaceutical Preparations